Altogether, we discovered that psychotropic treatment non-adherence among patients with psychiatric disorders was quite common. This analysis may serve as a high-grade ore for policymakers, though it must be interpreted with caution due to significant heterogeneity. Notwithstanding stringent methodology, depending on cross-sectional studies limits its clinical guidance.
No takes yet. Share an insight, caveat, or question.
Zewdu et al. (2025) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: